Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high21.00 08/08/16
52 week low13.50 14/01/16
52 week change 3.13 (21.01%)
4 week volume1,659,757 06/11/16

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
06/07/2015
Presenter: Kieron Harbinson, Group Finance Director
14/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hardman Research: Food intolerance driving growth

RNS Number: 3552Q Omega Diagnostics Group PLC 29 November 2016 Hardman Research: Food intolerance driving growth Food intolerance driving growth: Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence - Food Intolerance, Allergy & Autoimmune, Infectious Disease - ...

Holding(s) in Company

RNS Number: 0327Q Omega Diagnostics Group PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of...

Omega Diagnostics improves H1 pretax profit

Omega Diagnostics has improved its H1 pretax profit to 305,447, from 177,360.

Half-year Report

RNS Number: 6304P Omega Diagnostics Group PLC 21 November 2016 21 November 2016 OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2016 Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disea...

Hardman Research: Diagnosing growth opportunities

RNS Number: 7909N Omega Diagnostics Group PLC 31 October 2016 Hardman Research: Diagnosing growth opportunities Diagnosing growth opportunities: Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence - Food Intolerance, Allergy & Autoimmune, Infectious Disease - tha...

Trading Update and Notice of Interim Results

RNS Number: 6304M Omega Diagnostics Group PLC 17 October 2016 Omega Diagnostics Group PLC ("Omega" or "the Company") Trading Update and Notice of Interim Results Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following trading update for the six months to 30 September...

Result of AGM

RNS Number: 8212G Omega Diagnostics Group PLC 10 August 2016 Omega Diagnostics Group PLC ("Omega" or the "Company") Result of Annual General Meeting Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that at the Annual General Meeting held earlier today, all resolutions were du...

Omega Diagnostics secures £1.8m R&D grant

Omega Diagnostics has secured a Scottish Enterprise research and development grant of 1.8m. This represented a significan...

Fundamental DataMore

P/E ratio36
EPS0.5
Dividend yield0 %

Equity Research (ODX)

hardman & co
Omega Diagnostics Group PLC
29/11/2016
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...

Latest discussion posts More

  • Nice mention here

    Nice mention ...
    25-Nov-2016
    gretel
  • RNS : Richard Sneller continues to buy

    Buying quickly too - another almost 2.5m shares. He now has over 10%, with 11.45m ...
    24-Nov-2016
    gretel
  • Interview with FD and MD

    Encouraging comments here from the FD and MD (Andrew Shepherd). I wonder what the share price will be once the market latches on to the possibility of $115m of revenues ...
    22-Nov-2016
    gretel

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.34%
IQE22%
SAINSBURY(J)22%
CENTRICA17%
ROYAL BANK SCOT17%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX